PARADEEP · Chemicals
Paradeep Phosphates Ltd. reported revenue of ₹2,377 cr for April to June 2024, −22.2% on the year and +6.0% on the quarter.
Operating profit (EBITDA) was ₹146 cr, a margin of 6.1%, +742 bps on the year and −46 bps on the quarter.
The company swung to a net profit of ₹5.0 cr from a loss of ₹120 cr a year earlier, with earnings per share of ₹0.07.
Speciality chemicals are read on volumes and pricing, with Chinese supply a recurring swing factor; inventory destocking can hit a quarter without a change in demand. The quarterly statements do not carry volumes against prices, capacity utilisation and new molecules; those come with the filing read.
On earnings per share of ₹2.77 over the last four quarters, the stock at ₹147.22 trades at 53.1 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow, the auditor's review, segment results, one-off items line by line and what management said on the call.
Half or more of pre-tax profit came from other income. What is it, and does it repeat?
Other income was 146% of profit before tax.
Source: Quarterly statements
Margin rose sharply on flat revenue. Which cost fell, and will it stay down?
EBITDA margin 6.1%, +742 bps on the year (−46 bps on the quarter).
Source: Quarterly statements
Turned profitable from a loss a year ago.
Net profit ₹5.0 cr against a loss of −₹120 cr.
Source: Quarterly statements
Could not run on this quarter: Headline vs core profit, Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,595 cr | ₹2,243 cr | ₹2,377 cr | ₹4,619 cr | ₹4,990 cr | ₹4,194 cr | ₹4,504 cr | ₹6,872 cr | ₹5,749 cr | ₹4,702 cr | ₹6,124 cr | ₹7,364 cr |
| YoY | — | — | −22% | +25% | +92% | +87% | +89% | +49% | +15% | +12% | +36% | +7% |
| EBITDA margin | 10.9% | 6.6% | 6.1% | 11.0% | 8.8% | 9.1% | 12.9% | 9.6% | 8.2% | 9.4% | 11.8% | 5.6% |
| Other income, % of PBT | 6% | 119% | 146% | 6% | 15% | 25% | 8% | 9% | −4% | 21% | 8% | 11% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 29% | 18% | 59% | 24% | 28% | 28% | 25% | 27% | 22% | 23% | 25% | 26% |
| Net profit | ₹109 cr | ₹22.0 cr | ₹5.0 cr | ₹255 cr | ₹209 cr | ₹172 cr | ₹317 cr | ₹342 cr | ₹182 cr | ₹156 cr | ₹393 cr | ₹121 cr |
| YoY | — | — | — | +187% | +92% | +682% | +6,240% | +34% | −13% | −9% | +24% | −65% |
| Core profit YoY | — | — | — | +191% | +70% | — | — | +35% | −2% | −10% | +24% | −66% |
| EPS | ₹1.34 | ₹0.26 | ₹0.07 | ₹3.13 | ₹2.57 | ₹2.11 | ₹3.88 | ₹4.19 | ₹1.75 | ₹1.50 | ₹3.78 | ₹1.17 |
| Flags | · | 1 | 1 | ✓ | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 1 |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Paradeep Phosphates Ltd. reported revenue of ₹2,377 cr (−22.2% on the year) and net profit of ₹5.0 cr (— on the year) for April to June 2024.
1 check raised a question: Half or more of pre-tax profit came from other income. What is it, and does it repeat?
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.